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Abstract
Background: The study examined complementary and alternative medicine (CAM) usage by
patients attending a Turkish gastroenterology outpatient clinic.
Methods: The survey was conducted on 216 patients presenting with gastrointestinal problems
during their first visit to the clinic using a 31 item, self-report questionnaire between May and
October 2005. Data included information on patient demographics and their gastrointestinal
symptoms, as well as items to identify CAM use and patient satisfaction with these therapies.
Results: Seventy-nine patients (36.6%) reported using one or more forms of CAM. The most
commonly used therapy was herbal therapy, usually taken as a tea or infusion. These were used by
27 people (29%) in this subgroup. Common indicators for their use were epigastric pain,
constipation, bloating and dyspepsia or indigestion. CAM use among upper GI patients was
marginally higher than lower GI patients (41.8% versus 41.2%), but the highest usage was amongst
patients with liver disease where 53.8% reported using one or more CAM therapy. About half of
the patients learned about CAM from their relatives or friends, with more women than men using
the therapies (p < 0.05). Clinical characteristics such as diagnosis, duration of symptoms and prior
surgical intervention did not differ between users and non-users of CAM therapies. Multivariate
analysis showed that being female and higher educational status were positively associated with
CAM usage (p < 0.05).
Conclusion: CAM usage in our sample of gastrointestinal patients was lower than that described
in other countries and other chronic disease groups. This could be due to their low perceived
efficacy, or the relatively transient duration of symptoms experienced by the sample. Healthcare
professionals need however, to be aware of CAM usage in order to educate patients appropriately
about possible adverse effects or drug-interactions.
Background
The term complementary or alternative medicine (CAM)
is used to describe a range of medical and healthcare sys-
tems, practices or products used by patients without med-
ical supervision. These generally lie outside conventional
medicine and can be classified into five main categories:
alternative medical systems, mind-body interventions,
biologically-based therapies, physical manipulation or
body-based methods, and energy therapies [1]. Therapeu-
tic approaches and preferences vary according to the
socio-cultural, historical and at times, religious back-
ground of the individual concerned [2], but their use is
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increasing rapidly, particularly amongst those with
chronic illnesses such as diabetes, osteoporosis, liver dis-
ease, and among cancer patients [3-5]. CAM therapies
include ayurvedic medicine, acupuncture and acupres-
sure, herbalism, homeopathy, dietary restrictions or vita-
min supplementation, as well as spiritual healing and
prayer [6].
CAM therapies have variously been described as a secular
trend, an epidemic or a fad [7,8], and concerns still exist
about the evidential basis for many such therapies
amongst medical practitioners [7]. Gastroenterologists
frequently have to address the adverse effects of tradi-
tional herbal medicines in particular, and many still view
them skeptically, although patients are increasingly seek-
ing advice about their perceived benefits. Physicians often
omit to ask whether the patient is using such therapies
however, and some patients are reluctant to discuss such
issues for fear of reproach or medical censure [9], which
may impact upon the reliability of patient reported symp-
toms when making a definitive diagnosis as to the cause
of the patient's problems.
Recent studies indicate that the percentage of adults using
CAM therapies for their gastrointestinal symptoms ranges
from 20 to 26% [1,10], but patients with functional gas-
trointestinal disorders are more likely to make use of
them, as are those with chronic gastrointestinal condi-
tions [11]. In Turkey, research into CAM use is based
mainly on small-scale studies in patients with a clearly
defined profile such as cancer [4,12], and several national
studies suggest that CAM usage may range from 22-84%
of patients, with a median usage of 46% [12]. To the best
of our knowledge however, there is no study addressing
the use of CAM therapies in Turkish gastrointestinal
patients at the present time, hence the decision to conduct
a cross-sectional survey among patients attending the out-
patient GI clinic. The first aim of the study was to deter-
mine the frequency and types of CAM therapy currently
used by Turkish gastrointestinal patients, and the second
was to examine those factors which determine whether
patients used CAM therapies or not.
Methods
A descriptive cross-sectional survey was conducted in the
gastroenterology outpatient clinic at a private hospital in
Ankara, Turkey. Institutional approval to conduct the
study was obtained from the Institutional Review Board
of 29 Mayis Medical Center and informed consent was
obtained from all of the patients involved in the study.
Data were collected over a period of 8 months (March to
September 2005) by asking all of the 216 patients admit-
ted consecutively to the clinic for the first time to partici-
pate in the study. Respondents were informed that the
objective of the study was to identify the extent to which
patients used, and were satisfied with CAM therapies.
Additional information was provided on the cover page of
the survey form, which also outlined the purpose of the
study and assured patients that respondent confidentiality
would be maintained. Patients were then asked to com-
plete the survey while waiting to see the gastroenterologist
and return the form before leaving the clinic. A nurse
assisted patients if they raised any questions, or encoun-
tered difficulties in completing the form. After completion
of the examination, patients' definitive or probable diag-
noses were noted on the forms, together with other clini-
cal data.
The survey tool was based on that developed by Molassi-
otis et al. [13] and adapted by Kav et al. [4] for use in Turk-
ish cancer populations. The questionnaire included
questions about the patient's age, gender, occupation,
educational attainment and marital status in addition to
questions about their use of CAM therapies. The question-
naire was further modified in order to include a list of
common gastrointestinal symptoms, their duration, and
details about their management, together with informa-
tion on the patient's surgical history and, where indicated,
any adverse reactions arising from these or CAM usage.
The form was considered to have an acceptable level of
face-validity for the purposes of the study.
The survey tool contained 31 items in total, and took
around 10 minutes to complete. The questionnaire was
pretested in 10 subjects to ensure that it could be read eas-
ily and clearly understood before the main survey was
conducted. Patients completed the demographic and clin-
ical information section. If they had not used one of the
24 CAM therapies listed on the form, they were asked to
indicate this and go no further. If they did use one or more
CAM therapies, they were asked to state which one(s), and
to evaluate their usefulness. Some of the therapies listed
included the use of herbs, animal extracts, naturopathic or
homeopathic remedies, and vitamin supplementation.
The remaining questions asked about the method and fre-
quency of use, reasons for use, any beneficial effect expe-
rienced, any side-effects, and the cost of the therapy. A
visual analog scale was used to determine satisfaction and
perceived effectiveness. The final question asked where
patients had received their initial information about the
therapy.
Means and percentages were calculated for demographic
variables such as age, length of symptom duration etc.,
and participants were categorized as being either CAM
users or CAM non-users. Symptoms suggestive of func-
tional gastrointestinal problems included abdominal
pain, bloating, regurgitation, constipation or diarrhea.
Respondents were further divided into those with upper
or lower GI symptoms and those with liver disease. Chi-BMC Complementary and Alternative Medicine 2009, 9:41 http://www.biomedcentral.com/1472-6882/9/41
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square tests and t test were used to determine which of the
socio-demographic and medical variables were related to
the use of CAM therapy, whilst means were compared
among groups using ANOVA. Binary logistic regression
analysis was performed in order to identify predictors of
CAM usage amongst respondents. All data were analyzed
using the Statistical Package for the Social Sciences (SPSS)
version 11.5 and a P value less than .05 was considered
significant.
Results
The characteristics of respondents were as follows. The
mean age of the patients was 50.15 ± 13.03 years (range
18-75 years). Most respondents were married (79%) and
62.5% were female. Only 40.8% had a received education
beyond high school level, 46.8% were retired, and 94%
described themselves as living in an urban area.
Ninety-three patients reported using one or more CAM
therapies in the previous year, the most frequent being
generic 'herbal' preparations (27 patients) in addition to
thyme (11 patients), linseed (11 patients), stinging nettle
(10 patients), and cassia senna (10 patients) (Table 1).
Herbs were usually consumed as teas or infusions, but
were occasionally mixed with yogurt or honey. The ensu-
ing preparations were consumed 1-2 times per day. High
dose vitamin or mineral supplements were used by 9
patients and 1 person used coenzyme Q10. In contrast to
herbal or 'natural' remedies, only 2 patients reported
using ayurvedic medicine, 3 said that they meditated, and
2 that they used prayer as a means of gaining symptom
relief. One other patient used a support group. Eighteen
CAM users (22.8%) were using two or more methods at
the time of the study and others had done so previously.
The most frequent indications for CAM use were epigas-
tric pain (37 people or 29.8%), constipation (21 people
or 16.9%), bloating (18 people or 14.5%) and dyspepsia
or indigestion (12 people or 9.6%) (Table 2). Twenty-five
CAM users (20.4%) said that they were using one or more
of the therapies for indications other than gastrointestinal
symptoms such as weight loss or to reduce their choles-
terol.
When asked what benefit they had expected from CAM
and what benefits they had actually received, 35 patients
(31.5%) said that they were used to "improve physical
well-being" whilst 31 (27.9%) felt that they "might help"
and "can't hurt". Twenty patients (18%) said they "desired
to do everything they could to fight the disease", and 10
patients (9%) though that they would improve their emo-
tional well-being (Table 3).
Thirty-two CAM users (40.5%) said that they were "feeling
better both physically and emotionally" but the same
number said that they had experienced "no change or
benefits". Seventeen (21.5%) believed the therapy would
increase the body's ability to fight their disease and 11
(13.9%) that it gave them more hope and optimism.
Three reported a decrease in the side effects of their con-
ventional treatment, but this was not further explained in
the completed survey forms. The median cost for CAM
products was 11 Turkish Lira ± 10.8 (range 1-120 Lira) per
month, which is roughly 88 US$ per year, but information
on cost was only provided by 56.9% of the patients that
reported CAM use. Only two patients collected and pre-
pared their own herbs however.
Table 1: Prevalence and type of CAM therapies used by the patients
CAM use n( % )
Yes 79 36.6
No 137 63.4
Total 216 100.0
Types of herbs/supplement (n = 93)* n( % )
Herbal Tea 27 29
Linseed 11 11.8
Thyme 11 11.8
Stinging nettle 10 10.8
Cassia senna 10 10.8
Vitamin 88 . 6
Others (rosehip, artichoke, walnut, parsley, aloevera, ginger) 16 17.2
Total 93 100
*Some items may have multiple answersBMC Complementary and Alternative Medicine 2009, 9:41 http://www.biomedcentral.com/1472-6882/9/41
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Table 4 summarizes the information sources used by CAM
users. Just under half (45.9%) learned about the therapy
from relatives or friends. Thirteen (16.4%) reported that
they had experienced adverse effects such as nausea,
abdominal pain and diarrhea as a result of their use.
Patient satisfaction with CAM therapies was evaluated on
a visual analogue scale of 1-7 with higher scores indicating
a higher level of satisfaction. The mean satisfaction for
CAM therapies was 3.86 ± 2.3 and the mean for their over-
all effectiveness was 3.83 ± 2.3 (range: 1-7).
When we compared the demographic details of CAM
users and non-CAM users, we found no significant differ-
ence between the two groups with regard to age, occupa-
tional or previous medical treatment status (Table 5).
More women within the sample were using CAM thera-
pies than men (p < 0.05), and being single was also posi-
tively and significantly correlated with CAM use (p <
0.05). There was also a positive correlation at the level of
significance (p < 0.05) between CAM usage and the edu-
cational level of respondents. CAM use among upper GI
patients was marginally higher than lower GI patients
(41.8% versus 41.2%), but the highest usage was amongst
Table 2: Most common symptoms experienced by CAM users
Which symptoms do the patients use CAM for? N %
Epigastric pain 37 29.8
Constipation 21 16.9
Bloating 18 14.5
Dyspepsia/indigestion 12 9.6
Diarrhea 43 . 2
Retrosternal burning 43 . 2
Regurgitation 32 . 4
Others (non- GI problems; to lower cholesterol, to lose weight) 25 20.4
Total * 124 100
*Some items may have multiple answers
*Some items may have multiple answers
Table 3: Patient responses on reasons for using CAM
Reasons for using CAM (n = 79)* N%
Improve physical well-being 35 31.5
"Might help, can't hurt" 31 27.9
Desire to do everything possible to fight the disease 20 18.0
Improve emotional well-being 10 9.0
To directly fight the disease with alternative therapy 9 8.1
To support treatment and decrease treatment side-effects 4 3.6
Not satisfied with the treatment 21 . 9
Total 111 100
*Some items may have multiple answersBMC Complementary and Alternative Medicine 2009, 9:41 http://www.biomedcentral.com/1472-6882/9/41
Page 5 of 9
(page number not for citation purposes)
patients with liver disease where 53.8% reported using
one or more CAM therapy. There was no statistically sig-
nificant difference however, between gastrointestinal dis-
ease types and CAM usage.
The length of CAM usage was classified as <1 year, 2-5
years, 6-10 years, and >11 years. The results under these
categories were 57.1%, 23.6%, 9% and 10.4% respectively
for those who reported using such therapies. No statistical
significance was observed between these categories, or in
respect of the length of time that a patient had gastrointes-
tinal symptoms or a medical diagnosis for their underly-
ing condition (ANOVA, F = 1.493, p = 0.223). As a
proportion of the entire sample, CAM usage was more fre-
quent in those who had experienced symptoms for 11
years or more (12 out of 22 patients), but this finding was
not statistically significant when the data were analyzed.
Sixty patients in the sample reported that they had previ-
ously undergone surgery for their gastrointestinal prob-
lems. For the most part, procedures were relatively minor,
but some had clearly experienced major procedures to the
colon and stomach. Others had also undergone cardiovas-
cular surgery for unrelated health problems. When we
analyzed patients' surgical histories in relation to CAM
use, the results were not statistically significant (X2 =
0.376, p = 0.326). We were unable to do an analysis
between procedure types however, as we did not have
access to the patients' detailed medical records and were
reliant on patient recall in estimating the extent of the sur-
gery described. There was no statistical difference how-
ever, between surgical intervention and CAM use in either
the CAM user and non-Cam user groups (X2 = 0.169, p =
0.395). Current medical treatment for gastrointestinal
problems also showed no statistical significance in rela-
tion to CAM usage (X2 = 0.925, p = 0.206).
Those variables that did differ between the users and non-
users of CAM therapies were further analyzed using uni-
variate logistic regression analysis to see whether they had
any predictive value. Three variables were reliable predic-
tors of CAM usage. These were gender (OR:2.37, %95CI
1.29-4.35, p < .05), education beyond high school level
(OR:2.06, %95CI 1.17-3.64, p < .05) and marital status
(OR:1.54, %95CI 1.00-2.36, p < .05). These predictors
were entered into a multivariate logistic regression model
together with details of the patient's disease status. A mul-
tivariate analysis of patient demographic data and clinical
status showed that the two predictive variables of CAM
use were gender (OR: 2.80, %95CI 1.44-5.41, p < .05) and
education level (OR: 2.17, %95CI 1.19-3.95, p < .05).
Marital status was not predictive of CAM use in this anal-
ysis. The presence of a medical diagnosis of gastroesopha-
geal reflux was predictive of non-use of CAM therapies
(OR: 0.33, %95CI .15-.74, p = .005), possibly because of
their unpleasant taste or immediate effects on the condi-
tion itself. These three predictors explained 63.6% of the
CAM user responses in this analysis whereas age, time
since diagnosis, prior surgical intervention, and medical
treatment status were not significant predictors of CAM
usage.
Discussion
This is the first cross sectional study of the incidence of
CAM use in patients admitted to a gastroenterology out-
patient clinic in Turkey. In contrast to other Turkish stud-
ies, which mostly included cancer patients, our results
showed a lower uptake of CAM therapies by patients with
gastrointestinal disorders (36.6%) [12]. Most of the stud-
ies from Turkey dealt with chronic diseases, which are pre-
dictors for higher CAM usage. Kav et al. for instance,
found that most cancer users of CAM therapies are over 50
years of age, female, and in contrast to the current study,
had a lower level of educational attainment [12]. The
results are similar to other European and North American
studies, with the exception perhaps, of educational attain-
ment [7,11]. The high prevalence of CAM usage among
Turkish cancer patients reported by Kav et al. cannot be
regarded as national estimate for the use of CAM therapies
in the general population of Turkey however, and may
instead, reflect the relatively high availability and uptake
of CAM therapies by patients in cancer and palliative care
settings [12].
Another interesting finding was that some CAM users
were using one of more therapies for purposes other than
Table 4: Information Sources for Users of CAM
Source of information n (%)
Friends 43 33.3
Book/magazine/newspaper 20 15.5
Media (TV/radio) 20 15.5
Family 16 12.4
Doctors 13 10.1
Other patients 6 4.7
Internet 6 4.7
CAM vendor 4 3.1
Nurses 1 0.7
Total 129 100
*Some items may have multiple answersBMC Complementary and Alternative Medicine 2009, 9:41 http://www.biomedcentral.com/1472-6882/9/41
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the control of GI symptoms. These included weight loss,
control of cholesterol and the improvement of general
wellbeing. If we had excluded this group of patients from
the analyses, then CAM usage amongst gastrointestinal
patients might be as low as 25.5%. These results are con-
sistent with previous findings which place the level of
CAM usage for gastrointestinal problems at 20-26% [1,2].
This figure is generally lower than that estimated for the
general population of Turkey, where the use of traditional
herbal remedies in particular is very common, and the
number of patients looking for non-conventional thera-
pies to manage the effects of both chronic disease and can-
cer is increasing [2,4,12,13]. This is consistent with the
reported growth in the uptake of CAM therapies in the
U.S. and elsewhere, where the proportion of people using
CAM therapies within a twelve month period in the gen-
eral population increased from 33% to 42% between
1990 and 1997, and is likely to be slightly higher at the
present time [1,6]. It has been estimated that 28.9% of
U.S. adults regularly use one or more CAM therapies, 9.6-
12.1% of which are in the form of herbal products [1].
Herbal medicine was the most common CAM modality in
our survey however, which may highlight cultural and
ethnic differences in preference for specific CAM therapies
in different countries [2].
Many patients use CAM for problems like irritable bowel
syndrome, constipation, upset stomach or intestinal can-
cer. Patients with chronic or refractory gastrointestinal
problems, such as functional gastrointestinal disorders
(FGIDs) and inflammatory bowel disease (IBD) tend to
use herbal products most frequently [5,8]. Overall, 10%
of herbal therapy is used for digestive symptoms and up
to 30% of patients with chronic liver disease and 40% of
Table 5: Characteristics of users and non-users of CAM therapy
Users (n = 79) Non-user (n = 137) Significance
Age
(year, mean ± SD) 49.9 ± 12.8
(range:19-75)
50.3 ± 13.2
(range:18-75)
*NS
t = 0.235 p = 0.904
Gender
Female 59 (43.7%) 76 (56.3%) **
x 2 = 7.889 p = 0.004
Male 20 (24.7%) 61 (75.3%)
Marital Status
Married 58 (34.1%) 112 (65.9%) **
t = 1.995 p = 0.047
Divorced/widowed 9 (34.6%) 17 (65.4%)
Single 12 (60.0%) 8 (40.0%)
Education
Up to High School 38 (29.6%) 90 (70.4%) **
x 2 = 6.286 p = 0.012
Beyond high school 40 (46.5%) 46 (53.5%)
Occupation/Working status
Not working/Housewife 58 (38.4%) 93 (61.6%) *NS
x 2 = 0.730 p = 0.393
Employed 21 (32.3%) 44 (67.7)
Diagnosis
Gastritis/Dyspepsia 38 (41.8%) 53 (58.2%)
GERD 13 (20%) 52 (80%) *NS
t = 0.377 p = 0.706
Liver diseases (hepatitis, NASH) 14 (53.8%) 12 (46.2%)
Lower GI problems (constipation) 14 (41.2%) 20 (58.8%)
Treatment status
Receiving active treatment 44 (39.6%) 67 (60.4%) *NS
x 2 = 0.925 p = 0.336
No current treatment 35 (33.3) 70 (66.7%)
Percentages are based on row total; *NS, Not significant (p > 0.05); ** significant (p < 0.05)BMC Complementary and Alternative Medicine 2009, 9:41 http://www.biomedcentral.com/1472-6882/9/41
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patients with irritable bowel syndrome claim to have used
some form of herbal medication in the past [1]. Since no
single treatable processes are known to cause these dis-
eases, conventional treatment is targeted towards the
management of symptoms rather than achieving a cure,
and patients are more likely to use CAM as an adjunct to
conventional medicine in such circumstances [1,5]. The
literature shows, in common with our own study, that
female gender is most predictive of CAM use both gener-
ally, and amongst this group of patients [6,14].
The use of herbal therapies in our study was lower than
that reported in other Turkish studies however [12], and
the low reported usage may be due to the fact that CAM
users do not always consider themselves to be using 'com-
plementary' or 'alternative' medicines. A further explana-
tion for the low use of CAM therapies in our sample might
be that this study was conducted in a large urban area
where CAM usage, and in particular, the use of herbal
remedies so common elsewhere in Turkey might not gen-
erally be recommended or practiced. The age range repre-
sented by our sample may also have affected the outcome
(mean 50 ± 13) as there is an apparent decline in CAM
usage with increasing age. Within our sample, most
respondents were uncertain about the benefit of CAM and
in those taking them for general health benefits, subjec-
tive reported improvements tended to be quite low. The
herbs used most commonly as single agents were linseed,
thyme, stinging nettle and cassia species which are com-
monly used for gastrointestinal problems such as bloating
and constipation. What differed in those with an underly-
ing gastrointestinal pathology was the use of cassia senna
teas, a popular herbal preparation which is widely
claimed to be beneficial in the treatment of constipation.
It was noticeable that most of the respondents using
herbal therapies believe that 'natural' equates with 'safe'
and almost 30% of patients reported that such prepara-
tions cannot cause any harm. However, herbal medicines
have the potential to elicit severe adverse reactions
because of contamination with heavy metals or their
direct toxic effects, and it is interesting that most of the
CAM users in our study obtained their herbal preparations
from markets or herbalists which are completely outside
the control of the Ministry of Health, and for which purity
cannot be guaranteed. This finding does concern us in
respect of patient safety, since whilst only 16% of the users
in our study reported adverse effects like upset stomach,
elevations in liver function tests were also noted. Herbs
are dilute natural drugs containing many different chemi-
cals, and their effects may be unpredictable. Few have
been tested for their side effects, quality, or the potential
for cross contamination by biological and chemical pol-
lutants in the environments in which they are grown,
transported or sold [15-18].
Whilst mind-body interventions such as prayer and med-
itation were also included as possible CAM modalities in
the survey, our results show that these were not frequently
used by our sample. One explanation could be that most
of our patients engage in regular prayer as part of their
daily religious observance and do not regard it as a 'ther-
apy'. Similarly, in spite of recent claims made for the effi-
cacy of probiotics for the management of symptoms
caused by lower GI problems and colitis [16-18], we did
not encounter anyone who reported using these as part of
their self-management for these problems. Probiotics in
the form of a pill are usually only provided on prescrip-
tion in Turkey and must be purchased from pharmacies.
This may limit their use, whilst those found in commer-
cial foodstuffs such as yogurts, may not be regarded as
CAM therapy worthy of reporting.
CAM users usually take advice from friends and family
members about the use of different therapies without the
encouragement or knowledge of their physicians [19].
This was certainly the case in our study, followed by the
media, which was the second source of information about
these therapies. This is an important reminder that physi-
cians should inquire specifically about use of herbal prep-
arations when seeing patients for the first time, and
ascertain what patients know about them. Interestingly,
and in comparison to many other countries, the internet
played a very small part in informing patients about the
proclaimed benefits or daily use of herbal remedies or
other CAMs in our study, but this is not surprising given
the low coverage of the general population as a whole by
information technologies such as the internet. Younger
people have better access to computers and web based
information which may make them more likely to try
CAM therapies for themselves, and this may account for
some of the age difference in CAM usage in our survey.
Our study was for the most part in agreement with the
findings of others however, that CAM users are more
likely to be younger, better off and predominantly, well-
educated women, since our analysis of sociodemographic
data confirmed that gender and educational level were
predictive variables of CAM usage.
There are no figures available for the incidence of gas-
trointestinal symptoms within the Turkish population as
a whole, but two studies from the UK and Japan report
incidences of between 10-25% [5,20]. Transient gastroin-
testinal symptoms were reported more commonly by
women in these studies, most of whom were likely to treat
themselves with CAM than to visit a physician [20].
Within the general population, the majority of transient
gastrointestinal problems are likely to be self-limiting and
easily managed without medical assistance. People learn
from each other and generally share practical advice
which may result in the use of locally available remedies,BMC Complementary and Alternative Medicine 2009, 9:41 http://www.biomedcentral.com/1472-6882/9/41
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as seen by the list of common herbs used within our own
sample.
Patients with functional and inflammatory bowel diseases
are known to use CAM therapies more often than other
groups for symptoms which include bloating, indigestion,
constipation, diarrhea and dyspepsia [9,21]. These
patients used CAM therapies more extensively (almost
44% of patients with symptoms), and they tend to use
those which have selective effects on gastrointestinal
motility such as cassia extracts and commercially prepared
herbal teas which also contain senna  in significant
amounts. However; gastroesophageal reflux disease
(GERD) tended to be associated with the non-use of CAM
therapies, possibly because the signs of GERD are associ-
ated with non-gastrointestinal problems. Severe chest
pain or retrosternal burning may cause anxiety in patients
who may seek urgent medical care for organic disease such
as cancer or cardiac problems rather than reach for a local
indigestion remedy [22]. Although the number of patients
diagnosed with liver disease was low in our study, half of
these patients used one or more forms of CAM therapy.
One possible explanation for this is the severe and debili-
tating nature of liver disease which may induce patients to
try everything and anything to overcome the disease and
its impact. This observation requires further investigation
in future studies however.
The study reported in this paper does have a number of
limitations. Patients may have been reluctant to disclose
their use of CAM therapies, or may have misconstrued
them as normal parts of their diet or daily routine, result-
ing in an under-reporting of their use. Some patients did
have problems recalling whether they had used such ther-
apies at any time in the previous year, so possible recall
bias cannot be eliminated as a limitation of the study. In
spite of these limitations, the study clearly shows some of
the factors associated with CAM use in a Turkish popula-
tion of gastrointestinal patients, although it is difficult to
compare this with general population data as this is cur-
rently unavailable. The findings do display certain similar-
ities with those conducted in other countries however, not
least in respect of the predictive variables most likely to
influence their use. This is not an insignificant finding
given that the use of specific CAM therapies varies
between countries depending upon cultural, historical,
geographical and political influences. The lower reported
usage of CAM therapies in our study might also reflect the
highly urbanized nature of our sample in relation to the
few Turkish studies which currently exist, whilst other
parts of our sample (such as those with gastroesophageal
reflux disease) may deliberately eshew their use because of
the nature of their symptoms and their anticipated causes.
Conclusion
The rate of CAM use in patients with gastrointestinal prob-
lems is lower than those described in other Turkish stud-
ies, and also lower than that reported in other chronic
diseases both nationally and internationally, although
international data also support the finding that the level
of CAM use for general gastrointestinal problems is lower
than that for general populations as a whole. This could
be due to the low perceived efficacy of CAM modalities
and their relatively transient nature. Within this group
however, sociodemographic factors play an important
role in determining whether such interventions are used,
although certain disease groups (such as inflammatory
bowel disease and irritable bowel syndrome) also tend to
use them more often. These differences should be evalu-
ated with further studies using Rome III criteria.
The liberal and increasing use of over-the-counter proton
pump inhibitors or histamine receptor blockers could
also eradicate transient gastrointestinal symptoms very
quickly, and this may affect the reported usage of CAM
therapies. The addition of over-the-counter medicines to
future survey tools should be discussed, since the patient's
motive in taking them is the same: to get relief from symp-
toms without complicated referrals or medical consulta-
tions. Healthcare professionals need to be aware of the
effect which various CAM interventions and over-the-
counter medicines play in the self-management of such
symptoms, and should be prepared to educate and inform
patients appropriately about the safety, efficacy, indica-
tions and contraindications for their use whilst diagnos-
ing the underlying cause of these troublesome symptoms
as the first stage in their conventional medical manage-
ment.
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